MARKET

ANIP

ANIP

Ani Pharmaceutic
NASDAQ
67.52
-0.77
-1.13%
After Hours: 65.36 -2.16 -3.20% 18:30 04/04 EDT
OPEN
66.02
PREV CLOSE
68.29
HIGH
68.40
LOW
65.13
VOLUME
698.16K
TURNOVER
--
52 WEEK HIGH
70.00
52 WEEK LOW
52.50
MARKET CAP
1.47B
P/E (TTM)
-64.7425
1D
5D
1M
3M
1Y
5Y
1D
SRPT Stock Down After EMA Places Clinical Hold on DMD Gene Therapy
NASDAQ · 2d ago
BMRN's PKU Drug Palynziq Meets Goal in Late-Stage Pediatric Study
NASDAQ · 3d ago
ANI Pharmaceuticals To Present At RBC Capital Markets Conference; Webcast At 7:45 AM ET
NASDAQ · 3d ago
Is the Options Market Predicting a Spike in ANI Pharmaceuticals (ANIP) Stock?
Barchart · 3d ago
LXRX Stock Moves Up 30% in a Week: What is Driving This Rally?
NASDAQ · 4d ago
GRI Stock Down on Public Offering Despite Encouraging IPF Study Data
Barchart · 4d ago
Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree
NASDAQ · 4d ago
CHMP Issues Positive Opinion for Label Expansion of BMY's Opdivo
NASDAQ · 4d ago
More
About ANIP
More
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company engaged in developing, manufacturing, and commercializing therapeutics. Its Rare Disease and Brands segment consists of two reporting units. The Rare Disease unit consists of operations related to the development, manufacturing, and marketing of branded pharmaceutical products, with a focus on products used in the treatment of patients with rare disease conditions and consists of operations related to Cortrophin Gel, ILUVIEN and YUTIQ. In addition, the Brands reporting unit includes a portfolio of over 16 brand products that are principally sold in genericized markets. Its Generics and Other segment consist of operations related to the development, manufacturing, and marketing of generic pharmaceutical products, including those sold through traditional wholesale and retail sales channels, sales of contract manufactured products, royalties on contract manufactured products, product development services, and others.
Recently
Symbol
Price
%Change

Webull offers ANI Pharmaceuticals Inc stock information, including NASDAQ: ANIP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIP stock methods without spending real money on the virtual paper trading platform.